TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Neurodevelopmental scores at 2-year study visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Communication and Symbolic Behavior Scales Developmental Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who omit Radiation Therapy and are non-adherent to Endocrine Therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants who are treated with Breast Cancer Surgery + RT + AET
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Metabolite Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Live birth rate after the first transfer
Endpoint domain: Mortality/survival
Primary endpoint: Prevention of postoperative ileus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevention of nausea-vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline QTcF (ΔΔQTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline AUC of psilocybin and psilocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Cmax of psilocybin and psilocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Tmax of psilocybin and psilocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of daridorexant excreted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior Shoulder Endurance Test Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects Developing AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sleep architecture objective TST
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep architecture objective SOL
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep problems SSHS
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sternal Bleeding Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reoperation for Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Angio-IMR measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fibrosis improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcoholic relapse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pulmonary function (Forced Expiratory Volume in one second; FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinical Outcomes in Routine Evaluation-10 (CORE-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Young Person's-Clinical Outcomes in Routine Evaluation (YP-CORE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 6-month complete response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: European-Addiction Severity Index (EuropASI), Section E
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The PTSD Checklist for DSM-5 - short version (PCL-5 short)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-reported symptoms measured by EORTC QLQ-CX2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient-reported symptoms measured by PFDI-20
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient-reported symptoms measured by PFIQ-7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impaired Swallowing Safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Impaired Swallowing Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: % deuterium (2H) label from oxidation of d31-palmitic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility of the Cologuard test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver and pancreatic fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in pain as measured by the Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of narcotic medications consumed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: K-6 Psychological Distress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to First Occurrence of 3P-MACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse events reported by subjects
Endpoint domain: Adverse events/effects
Primary endpoint: ALS Functional Rating Scale, Revised (ALSFRS-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Performance scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to post-release initiation of ART medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to post-release initiation of PrEP medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinician-Rated PTSD Symptom Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self-Reported PTSD Symptom Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Anxiety Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eosinophilic bronchial mucosal tissue inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Modified Dynamic Gait Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Durability of pulmonary vein isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of patient interest in care navigation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of cardiac autonomic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PAV-free survival
Endpoint domain: Mortality/survival
Primary endpoint: change in ALSFRS-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment burden
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Rate of agreement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Outcome Expectation Sub-score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Goal Persistence Sub-score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Career Readiness Sub-score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Objective Muscular Strength Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stone-free rate (SFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urological outcomes
Primary endpoint: Global Patient Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total radioactive recovery rate in urine and feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gastrointestinal motility improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants Who Complete Initial Fecal Immunochemical Test (FIT) at 6 Months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Who Completed Colonoscopy at 6 Months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Smoking Status by Expired Carbon Monoxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects completing at least one year of therapy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Serum urate level < 6 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of participants with plasma HIV-1 RNA below 400 cp/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reach as measured by absolute number and proportion of individuals who participate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness as measured by risk perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adoption as measured by use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Children's Impact of Event Scale (CRIES-13) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptability of device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of device
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of study subjects with analyzable raw data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in positive emotional response
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vessel patency without restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence, seriousness, and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants adhering to the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participants retained in the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of patients with two of the following criteria ( Δ Qmax ≥ 50%, Δ IPSS ≥30%, Homogeneous necrosis observed on MRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients that meet the four evaluation criteria (Absence of AD Clavien-Dindo ≥ III + ΔQmax ≥ 50% + Δ IPSS ≥30% + IPSS-QoL score ≤2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False negative rates
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Treatment-Related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Fecal microbial population
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in steps per day at 6-month follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of alcohol drinks consumed per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Heme Oxygenase-1 Gene and Protein Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Detection of Endometriosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bonding accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hospital anxiety and depression scale outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of incorrect selections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menopause Specific Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acute gastrointestinal injury (AGI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients with Complete or Partial response at 52 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete expulsion of gallbladder sludge after three days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Complete expulsion of gallbladder sludge after six days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cumulative incidence of rebleeding at 30-day
Endpoint domain: Mortality/survival
Primary endpoint: Ductular reaction and cancer stem cells markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pain severity at 3 months postprocedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Weight-Related behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal optical density assessed by backscatter measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal optical density assessed by forward-scatter measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Spinal Anesthesia-Induced Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of the passive and active range of motion of the knee joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of isometric muscle strength of knee flexors and extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POC serum pregnancy testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Feasibility of capturing 3D images
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Maximum concentration at steady-state (Cmax, ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum concentration at steady-state (Cmin, ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve at steady-state (AUCtau, ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication and remission rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Function survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Disability Status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Painful episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: McGill Pain Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number and severity of injection reactions
Endpoint domain: Adverse events/effects
Primary endpoint: microbiome profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ABC (Activities-Specific Balance Coordination) Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Variation of respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Variation of SpO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Functional Activity Brief Scale (Pedi-FABS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Western Ontario Meniscal Evaluation Tool (WOMET)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percent of depression responders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in Depression Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dermatological Assessment Score (DAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of Restraint Use
Endpoint domain: Adverse events/effects
Primary endpoint: post-operation recurrence or death
Endpoint domain: Mortality/survival
Primary endpoint: Change in lung transcriptomic biomarkers of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in lung protein biomarkers of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reported quantity and severity of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with observed changes in blood pressure against baseline mmHg value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with observed changes in heart rate (BPM) against baseline value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Progression-Free-Survival rate at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Change in MIDAS Scale (Migraine Disability Assessment Scale)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percent of meals successfully Ordered and Delivered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost per Participant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Days of Continuous Glucose Monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Impact on Streptococcus mutans levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Area Under the Breast Milk Concentration-time Profile from time 0 extrapolated to infinite time (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed breast milk concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal half-life for breast milk (t 1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Composite Hearing in Noise Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Frequency Following Response (FFR): Cross Correlation of FFR and Stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in P300 amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in PWV (pulse wave velocity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: modified Medical Research Council (mMRC) dyspnoea scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental care reported
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Participants With Treatment Emergent Adverse Event (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Clinically Significant Changes in Physical Examination Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Clinically Significant changes in Laboratory Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants With Clinically Significant Changes in Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Clinically Significant Changes in Electrocardiogram (ECG) Readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative incidence of BC
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative recall rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of serious clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of diagnostic thoracic imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ICU-related health care utilization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Stress-related neural activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Long-term clinical outcome events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver Transplant Waitlist Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Clinical Events Potentially Related to Fat-Soluble Vitamin Deficiencies
Endpoint domain: Adverse events/effects
Primary endpoint: Delay in progression of neuroradiological manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Nutrition Algorithm Effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of identified seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of DB-1305/BNT325
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RP2D of DB-1305/BNT325
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes